Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Miotox vs Botox in Children with Cerebral Palsy
NCT06840158Phase 3Completed
- Sponsor
- Innopharm Healthcare
- Start
- Oct 2021
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in cerebral palsy (CP), sponsored by Innopharm Healthcare. Started Oct 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT06840158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06840158.